This report contains market size and forecasts of Natural Killer Cell Therapy in Global, including the following market information:
Global Natural Killer Cell Therapy Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Natural Killer Cell Therapy market was valued at 212 million in 2020 and is projected to reach US$ 487.7 million by 2027, at a CAGR of 23.2% during the forecast period.
We surveyed the Natural Killer Cell Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Natural Killer Cell Therapy Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Natural Killer Cell Therapy Market Segment Percentages, By Type, 2020 (%)
NK Cell Therapies
NK Cell Directed Antibodies

China Natural Killer Cell Therapy Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Natural Killer Cell Therapy Market Segment Percentages, By Application, 2020 (%)
Cancer
Gastrointestinal Diseases
Others

 

Global Natural Killer Cell Therapy Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Natural Killer Cell Therapy Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

 

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Natural Killer Cell Therapy Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Natural Killer Cell Therapy Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Nektar Therapeutics
Innate Pharma SA
Affimed
Chipscreen Biosciences
Glycostem Therapeutics
Fate Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
Nkarta Therapeutics
NantKwest

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here